GI Innovation is a dynamic biotechnology research company dedicated to integrating basic science with translational innovation to develop groundbreaking biologics. Focused on making a global impact, GI Innovation is committed to serving patients worldwide through cutting-edge advancements in immuno-oncology and inflammation/immunology diseases.
Located at 송파구 송파대로 167 문정역테라타워 A동 1116호 서울, Seoul 05855, KR as its primary address, GI Innovation leverages its proprietary GI-SMART platform technology to accelerate the creation of high-quality, multi-targeting fusion protein therapeutics. This efficient optimization process ensures high productivity and positions GI Innovation as a leader in the next generation of biologics development. With a strong emphasis on innovation and strategic partnerships, GI Innovation is poised for continued growth and success in the competitive biotechnology landscape.
GI Innovation's unwavering commitment to excellence and patient-centric solutions drives its mission to transform healthcare. As GI Innovation continues to expand its research and development efforts, it remains dedicated to pushing the boundaries of biotechnology and delivering innovative therapies that address critical unmet medical needs. We invite the management team at GI Innovation to create a customized and exclusive company showcase and product listing on our platform to further highlight their remarkable work.
Compare GI INNOVATION with 1 companies in Biotechnology-Research
| Comparison Field |
GI INNOVATIONMain Company |
CovanceView Profile |
|---|---|---|
|
Founded Year
|
— | 0 |
|
Company Size
|
— | 10,001+ |
|
City
|
서울, Seoul | Princeton, New Jersey |
|
Country
|
United States | |
|
Skills & Keywords
Comparing with main company
|
14 Total Skills
Biotechnology
Immuno-oncology
Biologics Development
Fusion Protein Therapeutics
GI-SMART platform
Inflammation/Immunology
Drug Discovery
바이오제약
NASH
단백질 신약
항암
Immuno-Oncology
알레르기
신약 개발
|
33 Total
33 Unique
Unique Skills:
Bioanalysis
Bioassays
Biologics
Biotech
Cardiovascular
Cell & Gene Therapy
+27
|
Other organizations in the same industry
This company is also known as